The HIV-1 tat protein modulates CD4 expression in human T cells through the induction of miR-222

RNA Biology

Volumn 11, Issue 4, 2014, Pages 334-338

  Orecchini, Elisa ^a   Doria, Margherita ^b   Michienzi, Alessandro ^a   Giuliani, Erica ^b   Vassena, Lia ^b   Ciafrè, Silvia Anna ^a   Farace, Maria Giulia ^a   Galardi, Silvia ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

CD4; HIV 1; MicroRNAs; NFkB; Post transcriptional regulation

Indexed keywords

CD4 ANTIGEN; MESSENGER RNA; MICRORNA 222; NEF PROTEIN; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR RELA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICRORNA; MIRN222 MICRORNA, HUMAN;

ARTICLE; CONTROLLED STUDY; FEMALE; HELA CELL LINE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; JURKAT CELL LINE; PROTEIN EXPRESSION; T LYMPHOCYTE; UPREGULATION; CELL LINE; GENE EXPRESSION REGULATION; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; T LYMPHOCYTE SUBPOPULATION;

ANTIGENS, CD4; CELL LINE; GENE EXPRESSION REGULATION; HIV INFECTIONS; HIV-1; HUMANS; MICRORNAS; NF-KAPPA B; RNA, MESSENGER; T-LYMPHOCYTE SUBSETS; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

EID: 84901395407     PISSN: 15476286     EISSN: 15558584     Source Type: Journal    
DOI: 10.4161/rna.28372     Document Type: Article

References (23)

1. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009; 136:215-33; PMID:19167326; http://dx.doi.org/10.1016/j.cell.2009.01.002
2. Swaminathan S, Murray DD, Kelleher AD. miRNAs and HIV: unforeseen determinants of host-pathogen interaction. Immunol Rev 2013; 254:265-80; PMID:23772625; http://dx.doi.org/10.1111/imr.12077
3. Huang J, Wang F, Argyris E, Chen K, Liang Z, Tian H, Huang W, Squires K, Verlinghieri G, Zhang H. Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes. Nat Med 2007; 13:1241-7; PMID:17906637; http://dx.doi.org/10.1038/nm1639
4. Nathans R, Chu CY, Serquina AK, Lu CC, Cao H, Rana TM. Cellular microRNA and P bodies modulate host-HIV-1 interactions. Mol Cell 2009; 34:696-709; PMID:19560422; http://dx.doi.org/10.1016/j.molcel.2009.06.003
5. Triboulet R, Mari B, Lin YL, Chable-Bessia C, Bennasser Y, Lebrigand K, Cardinaud B, Maurin T, Barbry P, Baillat V, et al. Suppression of microRNA-silencing pathway by HIV-1 during virus replication. Science 2007; 315:1579-82; PMID:17322031; http://dx.doi.org/10.1126/science.1136319
6. Sung TL, Rice AP. miR-198 inhibits HIV-1 gene expression and replication in monocytes and its mechanism of action appears to involve repression of cyclin T1. PLoS Pathog 2009; 5:e1000263; PMID:19148268; http://dx.doi.org/10.1371/ journal.ppat.1000263
7. Chiang K, Liu H, Rice AP. miR-132 enhances HIV-1 replication. Virology 2013; 438:1-4; PMID:23357732; http://dx.doi.org/10.1016/j.virol.2012.12.016
8. Galardi S, Mercatelli N, Giorda E, Massalini S, Frajese GV, Ciafrè SA, Farace MG. miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1. J Biol Chem 2007; 282:23716-24; PMID:17569667; http://dx.doi.org/10.1074/jbc.M701805200
9. Ciafrè SA, Galardi S. microRNAs and RNA-binding proteins: a complex network of interactions and reciprocal regulations in cancer. RNA Biol 2013; 10:935-42; PMID:23696003; http://dx.doi.org/10.4161/rna.24641
10. Zhong S, Li W, Chen Z, Xu J, Zhao J. MiR-222 and miR-29a contribute to the drug-resistance of breast cancer cells. Gene 2013; 531:8-14; PMID:23994196; http://dx.doi.org/10.1016/j.gene.2013.08.062
11. Galardi S, Mercatelli N, Farace MG, Ciafrè SA. NF-kB and c-Jun induce the expression of the oncogenic miR-221 and miR-222 in prostate carcinoma and glioblastoma cells. Nucleic Acids Res 2011; 39:3892-902; PMID:21245048; http://dx.doi.org/10.1093/nar/gkr006
12. Fiume G, Vecchio E, De Laurentiis A, Trimboli F, Palmieri C, Pisano A, Falcone C, Pontoriero M, Rossi A, Scialdone A, et al. Human immunodeficiency virus-1 Tat activates NF-κB via physical interaction with IκB-α and p65. Nucleic Acids Res 2012; 40:3548-62; PMID:22187158; http://dx.doi.org/10.1093/nar/gkr1224
13. Marban C, Su T, Ferrari R, Li B, Vatakis D, Pellegrini M, Zack JA, Rohr O, Kurdistani SK. Genome-wide binding map of the HIV-1 Tat protein to the human genome. PLoS One 2011; 6:e26894; PMID:22073215; http://dx.doi.org/10.1371/ journal.pone.0026894
14. Chang TC, Yu D, Lee YS, Wentzel EA, Arking DE, West KM, Dang CV, Thomas-Tikhonenko A, Mendell JT. Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet 2008; 40:43-50; PMID:18066065; http://dx.doi.org/10.1038/ng.2007.30
15. Lama J. The physiological relevance of CD4 receptor down-modulation during HIV infection. Curr HIV Res 2003; 1:167-84; PMID:15043201; http://dx.doi.org/10.2174/1570162033485276
16. Doria M. Role of the CD4 down-modulation activity of Nef in HIV-1 infectivity. Curr HIV Res 2011; 9:490-5; PMID:22103832; http://dx.doi.org/10. 2174/157016211798842125
17. Levesque K, Finzi A, Binette J, Cohen EA. Role of CD4 receptor down-regulation during HIV-1 infection. Curr HIV Res 2004; 2:51-9; PMID:15053340; http://dx.doi.org/10.2174/1570162043485086
18. Chang ST, Sova P, Peng X, Weiss J, Law GL, Palermo RE, Katze MG. Next-generation sequencing reveals HIV-1-mediated suppression of T cell activation and RNA processing and regulation of noncoding RNA expression in a CD4+ T cell line. MBio 2011; 2:e00134-11; PMID:21933919; http://dx.doi.org/10. 1128/mBio.00134-11
19. Mohammadi P, Desfarges S, Bartha I, Joos B, Zangger N, Muñoz M, Günthard HF, Beerenwinkel N, Telenti A, Ciuffi A. 24 hours in the life of HIV-1 in a T cell line. PLoS Pathog 2013; 9:e1003161; PMID:23382686; http://dx.doi.org/10.1371/journal.ppat.1003161
20. Lindwasser OW, Chaudhuri R, Bonifacino JS. Mechanisms of CD4 downregulation by the Nef and Vpu proteins of primate immunodeficiency viruses. Curr Mol Med 2007; 7:171-84; PMID:17346169; http://dx.doi.org/10.2174/ 156652407780059177
21. Dubé M, Bego MG, Paquay C, Cohen ÉA. Modulation of HIV-1-host interaction: role of the Vpu accessory protein. Retrovirology 2010; 7:114; PMID:21176220; http://dx.doi.org/10.1186/1742-4690-7-114
22. Lacoste A, Berenshteyn F, Brivanlou AH. An efficient and reversible transposable system for gene delivery and lineage-specific differentiation in human embryonic stem cells. Cell Stem Cell 2009; 5:332-42; PMID:19733544; http://dx.doi.org/10.1016/j.stem.2009.07.011
23. Matusali G, Potestà M, Santoni A, Cerboni C, Doria M. The human immunodeficiency virus type 1 Nef and Vpu proteins downregulate the natural killer cell-activating ligand PVR. J Virol 2012; 86:4496-504; PMID:22301152; http://dx.doi.org/10.1128/JVI.05788-11